In a previous study conducted by our group, we found that the tumor expression of B7-H4 was associated with poor PFS and OS in NSCLC patients receiving nivolumab but not in those treated with chemotherapy [12]. This evidence concerns the gene VTCN1 and non-small cell lung carcinoma.